Archive for the ‘research’ Category

8X More People Died from Clot Shot Than of COVID & Spike Protein Found in Brain of Vaxxed Parkinson’s Patient

https://expose-news.com/2023/03/01/covid-vaccination-8x-deadlier-than-disease/

8x more people died due to C-19 Vaccination over 6 months than died of COVID-19 over 18 months according to UK GOV.

BY  ON 

Important excerpts:

When you consider that testing was compulsory in hospitals, despite it not being written in law, and they used the PCR test notorious for producing false positives, it’s not hard to see how the Government managed to mix tens of thousands of people who actually died of other causes into the Covid-19 death statistics.

But after months of trying to conceal the data, the Office for National Statistics published a report which contained figures on deaths by vaccination status.

But those figures may have actually been published by accident.

A report published by the ONS on September 13th 2021 misled the public into believing the majority of Covid-19 deaths were occurring among the unvaccinated population. But the date parameters used in their report – January 2nd 2021 to July 2nd 2021- include a huge swathe of deaths that were suffered during the second alleged wave of Covid-19 in January 2021, when barely anybody was vaccinated.

(See link for article and graphs)

_________________

http://

Link

DarkHorse Podcast Clip Feb. 28, 2023

V-Spike protein present in brain of dead Parkinson’s patient

https://www.mdpi.com/2076-393X/10/10/…

76-year-old man with Parkinson’s disease Died three weeks after third COVID-19 vaccination

Family of the deceased requested an autopsy, due to ambiguous clinical signs before death. PD was confirmed by post-mortem examinations.

  • Signs of aspiration pneumonia and systemic arteriosclerosis
  • Histopathological analyses of the brain Acute vasculitis (predominantly lymphocytic)
  • Multifocal necrotizing encephalitis
  • Pronounced inflammation Glial and lymphocytic reaction
  • In the heart Signs of chronic cardiomyopathy
  • Mild acute lympho-histiocytic myocarditis and vasculitis Patient had no history of COVID-19
  • Immunohistochemistry for SARS-CoV-2 antigens (spike and nucleocapsid proteins) was performed.
  • Only spike protein but no nucleocapsid protein could be detected, within the foci of inflammation, brain and heart
  • Spike protein detected in the endothelial cells of small blood vessels.
Quotes from the paper

Since no nucleocapsid protein could be detected, the presence of spike protein must be ascribed to vaccination rather than to viral infection. The findings corroborate previous reports of encephalitis and myocarditis caused by gene-based COVID-19 vaccines. A causal connection of these findings to the preceding COVID-19 vaccination was established by immunohistochemical demonstration of SARS-CoV-2 spike protein. The methodology introduced in this study should be useful for distinguishing between causation by COVID-19 vaccination or infection in ambiguous cases. Clinicians should take note of such case reports for the sake of early detection and management of such adverse events among their patients.

A thorough post-mortem examination of deaths in connection with COVID-19 vaccination should be considered in ambiguous circumstances, including histology.

For more:

Category:

Activism, research, vaccines, Viruses

CA Ticks Spread Lyme But That’s Not the Whole Story

https://www.globallymealliance.org/blog/california-ticks-can-spread-lyme-disease-but-thats-not-the-whole-story

California Ticks Can Spread Lyme Disease…But That’s Not the Whole Story

by Paul Killinger on February 24, 2023

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >California Ticks Can Spread Lyme Disease…But That’s Not the Whole Story</span>
If you find a tick bite from an Ixodes tick in California, it’s important to consider possible exposure to pathogens that cause more than Lyme disease

Originally published on Medzulabs.org 

The risk of contracting Lyme disease from a tick bite in California has been well-documented, though there is still a long way to go in educating health providers and the broader community in the exposure risk from a tick bite. TickReport’s surveillance of ticks from California (and Oregon and Washington) goes back as far as 2006 and has expanded in recent years.

What ticks are endemic (commonly and consistently found in wild populations) to California and other West Coast states?

That’s a big question, and there are a few dozen species from different genera or families. Many of those species are specialist feeders and—if everything goes “right” in their life cycle—they will only feed on certain wild mammals, birds, or lizards and will bite humans very rarely. That’s doesn’t mean that finding one of these “specialists” attached to ourselves or a family member is impossible: it’s just much less common (and a topic we’ll try to visit soon in another post).

Our surveillance shows that the majority (91.5%) of human or human-adjacent (dogs, cats, horses, etc) tick bites are caused by the following ticks:

  • Ixodes pacificus (“Western black-legged tick,” a close relative of the Deer tick in the Eastern U.S.)
  • Dermacentor variabilis (“American dog tick”)
  • Dermacentor occidentalis (“Pacific Coast tick”)
  • Dermacentor andersoni (“Rocky Mountain Wood tick”)
  • Ixodes spinipalpis
  • Ixodes angustus
What pathogens can these ticks transmit to humans?

Vector competence (the ability of a vector like a tick to transmit a given disease-causing pathogen) tends to run along genus lines, so species within the Ixodes genus tend to be able to transmit pathogens X and Y but not Z, while Dermacentor species tend to transmit Z but not X and Y.

The most common pathogen found in California ticks is Borrelia burgdorferi, which causes Lyme disease in humans and pets. But there’s more than Lyme in those hills! If you find a tick bite from an Ixodes tick in California, it’s also important to consider possible exposure to these pathogens:

  • Borrelia miyamotoi: a bacterium that can cause hard tick relapsing fever—sometimes called Borrelia miyamotoi disease.
  • Anaplasma phagocytophilum: a bacterium that can cause Human granulocyctic Anaplasmosis.
*For every two ticks we find infected with Borrelia burgdorferi (Lyme disease bacteria), we detect one (or more) of these other pathogens

It’s vital that both tick surveillance and diagnostic approaches keep these non-Lyme pathogens in mind. For every two ticks we find infected with Borrelia burgdorferi (Lyme disease bacteria), we detect one (or more) of these other pathogens, so be sure to resist Lyme Tunnel Vision when responding to a tick bite! Common diagnostic tests for Lyme disease have a specific focus on Lyme disease and will not detect infection by these other pathogens if present. Make sure you and your doctor are considering the whole story of a tick bite.

To learn more about the pathogens we find in West Coast ticks, browse our real-time testing data at TickReport.com/stats. If you find and remove a tick, arrange for fast and accurate identification and testing at TickReport.com.
The above material is provided for information purposes only. The material (a) is not nor should be considered, or used as a substitute for, medical advice, diagnosis, or treatment, nor (b) does it necessarily represent endorsement by or an official position of Global Lyme Alliance, Inc. or any of its directors, officers, advisors or volunteers. Advice on the testing, treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient’s medical history. 

Paul Killinger oversees tick surveillance and pathogen testing at the TickReport testing lab in Amherst, Massachusetts. He has led the lab's public health education and outreach since 2018.

Category:

Activism, Anaplasmosis, Borrelia Miyamotoi (Relapsing Fever Group), Lyme, research, Testing, Ticks, Transmission

Reversible Dementia Caused By Lyme: Case Study

https://www.globallymealliance.org/news/2023-case-study-reversible-dementia-caused-by-lyme-disease

2023 Case Study: Reversible Dementia Caused by Lyme Disease

by Admin at Global Lyme Alliance on February 27, 2023

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >2023 Case Study: Reversible Dementia Caused by Lyme Disease</span>
A case of reversible dementia with Lyme treatment?

Annals of Geriatric Medicine and Research (Sanchini, C., et al.) 2.6.23, published “A case of reversible dementia? Dementia vs delirium in Lyme disease.” The report describes a case of a 75-year-old man who was admitted to the Alzheimer’s Disease Care Unit of the Institute Golgi in Abbiategrasso, Italy.

According to the case report, the man had been recently discharged from a local hospital with a diagnosis of “cognitive impairment, deficit of memory, and poor capacity of criticism compatible with degenerative disease.”

The patient was a multilingual interpreter with a high school degree. He enjoyed walking in the countryside with his dog, but he had been experiencing knee pain – for about a month. The pain would worsen and migrate to his other joints. The case also reports that he had been showing minor memory deficiency and ideomotor slowdown.

A CT scan showed abnormalities, but blood tests were within normal ranges, the only thing noted was increased inflammation. As time went on, the patient became more confused and disoriented, presenting with hallucinations, aggressive behavior, and insomnia.

With the patient having arthritis, he was tested for Lyme. Lyme antibodies were detected by the western blot. Initial intravenous ceftriaxone treatments did not alleviate the patient’s symptoms. Oral doxycycline was administered as well as a brief course of quetiapine to manage the hallucinations.

Soon after 6–7 days of antibiotic therapy, delusional symptoms and hallucinations were reduced, and his insomnia improved. Urinary incontinence completely resolved. His behavioral profile also improved, with a reduction in agitation, aggression, and depression. His language became more fluent and communicative.

Read the full case study here.

_______________

**Comment**

This proves that antimicrobial therapy helps Lyme/MSIDS patients, unfortunately, this patient will most probably suffer relapses as this duration of therapy has been proven to be insufficient time and time again.  Herein lies one of the most glaring problems that has not changed in 40 years.  The other glaring problem is the coinfection involvement that often occurs, necessitating different medications.

But, the band plays on…..

For more:

How many more dementia/Alzheimer’s patients have undiagnosed tick-borne illness?

Category:

Alzheimer's, Lyme, research, Treatment

Molecular Detection of Bartonellosis

https://wwwnc.cdc.gov/eid/article/29/3/22-1223_article

Bartonella spp. Infections Identified by Molecular Methods, United States

David W. McCormick, Sara L. Rassoulian-Barrett, Daniel R. Hoogestraat, Stephen J. Salipante, Dhruba SenGupta, Elizabeth A. Dietrich, Brad T. Cookson, Grace E. Marx1Comments to Author , and Joshua A. Lieberman1
Author affiliations: Centers for Disease Control and Prevention, Fort Collins, Colorado, USA (D.W. McCormick, E.A. Dietrich, G.E. Marx); University of Washington, Seattle, Washington, USA (S.L. Rassoulian-Barrett, D.R. Hoogestraat, S.J. Salipante, D. SenGupta, B.T. Cookson, J.A. Lieberman)
March, 2023

Abstract

Molecular methods can enable rapid identification of Bartonella spp. infections, which are difficult to diagnose by using culture or serology. We analyzed clinical test results of PCR that targeted bacterial 16S rRNA hypervariable V1–V2 regions only or in parallel with PCR of Bartonella-specific ribC gene. We identified 430 clinical specimens infected with Bartonella spp. from 420 patients in the United States. Median patient age was 37 (range 1–79) years; 62% were male.

We identified:

  • B. henselae in 77%
  • B. quintana in 13%
  • B. clarridgeiae in 1%
  • B. vinsonii in 1%
  • B. washoensis in 1% of specimens
  • B. quintana was detected in 83% of cardiac specimens
  • B. henselae was detected in 34% of lymph node specimens

We detected novel or uncommon Bartonella spp. in 9 patients. Molecular diagnostic testing can identify Bartonella spp. infections, including uncommon and undescribed species, and might be particularly useful for patients who have culture-negative endocarditis or lymphadenitis.

______________

Currently, 12 species of Bartonella genus are associated with human infection, but that number is constantly changing. Because Bartonella spp. infections are not nationally notifiable diseases, there is limited knowledge of the epidemiology of this disease in the US.  In my experience it is prolific.

For more:

Category:

Bartonella, research, Testing

Pacemakers for Lyme Carditis

https://danielcameronmd.com/pacemakers-for-lyme-carditis/

PACEMAKERS FOR LYME CARDITIS

pacemaker-lyme-carditis

Some patients with Lyme carditis (LC) require implantation of a pacemaker. Yeung and Baranchuk discussed the need for “preventing unnecessary implantation of permanent pacemakers in otherwise healthy young individuals” in the Journal of the American College of Cardiology in 2019.

By 

Lyme disease can directly infiltrate the heart leading to an exaggerated inflammatory response when spirochetes penetrate the heart. Lyme carditis can appear within 1 to 2 months after the onset of a Lyme disease infection, wrote Yeung and Baranchuk.¹ They point out, the most common presentation of LC (90%) is high-degree atrioventricular (AV) block (AVB).

AV block due to Lyme disease can be successfully treated with antibiotics in a hospital setting. However, in some cases, a temporary or permanent pacemaker is required. In reviewing the literature, Besant and colleagues found that 17.9% of patients with LC required a permanent pacemaker and 10.3% required a temporary and a permanent pacemaker.²

“High-degree atrioventricular block is the most common presentation of [Lyme carditis], and usually resolves with antibiotic therapy.”¹

Yeung et al. highlighted the importance of avoiding a permanent pacemaker “to prevent the inherent risks of pacemaker implantation, including periprocedural infections and complications, lead dislodgement, etc.”

Furthermore, the authors emphasized the importance in avoiding a permanent pacemaker in children. “An unnecessary pacemaker implantation would result in a subsequent lifetime of multiple pulse generator changes, psychological/physical sequelae, and burden of associated cumulative health care costs.”

They concluded, “A systematic approach to the diagnosis and treatment of LC will facilitate the identification of LC in patients with high-degree AVB, thus preventing unnecessary implantation of permanent pacemakers.”

Both a standard transvenous temporary pacemaker lead, or modified temporary–permanent transvenous pacing are available.

“In modified temporary– permanent transvenous pacing, an active fixation lead is attached to a resterilized permanent pace- maker generator taped to the patient’s skin and used as a temporary external device, which allows for early ambulation,” wrote Yeung and Baranchuk.

A permanent pacemaker has been recommended if AV conduction is not restored.

Related Articles:

Successful removal of pacemakers in patients with Lyme carditis

5 things to know about Lyme carditis

How common is Lyme carditis in patients referred for pacemaker implantation?

References:
  1. Yeung C, Baranchuk A. Diagnosis and Treatment of Lyme Carditis: JACC Review Topic of the Week. J Am Coll Cardiol. Feb 19 2019;73(6):717-726. doi:10.1016/j.jacc.2018.11.035
  2. Besant G, Wan D, Yeung C, et al. Suspicious index in Lyme carditis: Systematic review and proposed new risk score. Clin Cardiol. Dec 2018;41(12):1611-1616. doi:10.1002/clc.23102

For more:

Category:

Heart Issues, Inflammation, Lyme, research